News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by usefulcat on Friday June 11, 2021 @12:19PM (#27475241)
And in your hypothetical example, should insurance companies be required to cover this treatment? In other words, should other insurees be required to pay for it?
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by bitshiftfaced on Friday June 11, 2021 @12:22PM (#27475297)
It depends on whether or not the insurance company determines it's of value enough to their customers to include it in their insurance package. Insurance companies don't insure all prescription drugs.
[ Parent | on HN ]